Small Stocks, Big Money™

Following its successful Nasdaq debut last week, FatPipe (Nasdaq: FATN) is building on its momentum with the launch of Total Security 360—a unified SD-WAN and cybersecurity platform tailored for small and mid-sized businesses. This single stack solution simplifies deployment, enhances threat response, and lowers insurance costs, delivering enterprise-grade protection at an SMB-friendly price point.

Venu Holding Corporation (NYSE American: VENU) signed a transformative three-year national expansion deal with global consulting powerhouse Ryan LLC to accelerate the development of premium amphitheaters and concert venues through public-private partnerships. Leveraging Ryan’s expertise, VENU plans to secure two new projects per quarter—fueling rapid entry into top U.S. growth markets and tapping into the $79.7B global live entertainment boom projected by 2030.

ConnectM Technology Solutions (NASDAQ: CNTM) confirmed an updated implied equity valuation of $62M based on its latest share count, with the Buy-Out Group reaffirming its $1.60 per share cash offer. As the high-growth energy tech firm weighs the proposal, it has engaged ThinkEquity to explore all strategic options in alignment with shareholder interests.

OS Therapies (NYSE American: OSTX) announced compelling new data showing OST-HER2, in combination with radiation, halted tumor progression and delayed metastasis in dogs with unresected osteosarcoma—supporting its potential as a front-line therapy in humans. With over 500-day survival in a third of treated dogs and strong immune activation demonstrated in peer-reviewed studies, the Company is preparing for USDA conditional approval in 2025 while targeting FDA accelerated approval in metastatic osteosarcoma by year-end.